TY - JOUR
T1 - Measuring change in gait performance of children with motor disorders
T2 - assessing the Functional Mobility Scale and the Gillette Functional Assessment Questionnaire walking scale
AU - Ammann-Reiffer, Corinne
AU - Bastiaenen, Caroline H. G.
AU - Van Hegel, Hubertus J. A.
N1 - Funding Information:
We thank all children, adolescents, and parents who participated in this research project. We thank Corina Klo€ti and the physiotherapists who helped collect the data. Further, we acknowledge funding by the M€axi Foundation, Zurich, Switzerland, for this project. We also acknowledge the Children’s Research Center of the University Children’s Hospital Zurich and the Neuroscience Center Zurich. The authors have stated that they had no interests that might be perceived as posing a conflict or bias.
Funding Information:
We thank all children, adolescents, and parents who participated in this research project. We thank Corina Kl?ti and the physiotherapists who helped collect the data. Further, we acknowledge funding by the M?xi Foundation, Zurich, Switzerland, for this project. We also acknowledge the Children's Research Center of the University Children's Hospital Zurich and the Neuroscience Center Zurich. The authors have stated that they had no interests that might be perceived as posing a conflict or bias.
Publisher Copyright:
© The Authors. Developmental Medicine & Child Neurology published by John Wiley & Sons Ltd on behalf of Mac Keith Press.
PY - 2019/6
Y1 - 2019/6
N2 - Aim To examine the responsiveness and minimal important change (MIC) of two gait performance measures, the Functional Mobility Scale (FMS) and the Gillette Functional Assessment Questionnaire walking scale (FAQ), in a paediatric inpatient setting. Method Sixty-four children and adolescents with a motor disorder, including cerebral palsy, traumatic brain injury, or stroke (25 females, 39 males; mean age [SD] 12y 6mo [3y 2mo], range 6-18y 6mo), were recruited. Physiotherapists scored the FMS and FAQ at the start and end of active gait rehabilitation. Change scores were compared with changes in gait capacity tests, the walking item of the Functional Independence Measure for Children, and a global rating scale (GRS) on the physiotherapists' perceived change of the child's functional mobility. The GRS was also used to define the MIC. Results Change scores of the FMS and FAQ correlated between 0.35 and 0.49 with those of the capacity tests, 0.54 to 0.76 with the Functional Independence Measure for Children walking item change scores, and 0.57 to 0.76 with the GRS. The MIC values for the FMS and FAQ were 0.5 and 1.5 respectively. Interpretation FMS and FAQ can illustrate change in inpatient gait performance of children and adolescents with motor disorders. An improvement of one level in the FMS and two levels in the FAQ is considered as a clinically meaningful change.
AB - Aim To examine the responsiveness and minimal important change (MIC) of two gait performance measures, the Functional Mobility Scale (FMS) and the Gillette Functional Assessment Questionnaire walking scale (FAQ), in a paediatric inpatient setting. Method Sixty-four children and adolescents with a motor disorder, including cerebral palsy, traumatic brain injury, or stroke (25 females, 39 males; mean age [SD] 12y 6mo [3y 2mo], range 6-18y 6mo), were recruited. Physiotherapists scored the FMS and FAQ at the start and end of active gait rehabilitation. Change scores were compared with changes in gait capacity tests, the walking item of the Functional Independence Measure for Children, and a global rating scale (GRS) on the physiotherapists' perceived change of the child's functional mobility. The GRS was also used to define the MIC. Results Change scores of the FMS and FAQ correlated between 0.35 and 0.49 with those of the capacity tests, 0.54 to 0.76 with the Functional Independence Measure for Children walking item change scores, and 0.57 to 0.76 with the GRS. The MIC values for the FMS and FAQ were 0.5 and 1.5 respectively. Interpretation FMS and FAQ can illustrate change in inpatient gait performance of children and adolescents with motor disorders. An improvement of one level in the FMS and two levels in the FAQ is considered as a clinically meaningful change.
KW - CEREBRAL-PALSY
KW - RELIABILITY
KW - ABILITY
KW - ADOLESCENTS
KW - VALIDITY
KW - OUTCOMES
KW - QUALITY
KW - COSMIN
U2 - 10.1111/dmcn.14071
DO - 10.1111/dmcn.14071
M3 - Article
C2 - 30341775
SN - 0012-1622
VL - 61
SP - 717
EP - 724
JO - Developmental Medicine and Child Neurology
JF - Developmental Medicine and Child Neurology
IS - 6
ER -